Changing aspects in the evaluation and treatment of patients with benign prostatic hyperplasia

被引:6
|
作者
Lam, JS
Cooper, KL
Kaplan, SA
机构
[1] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[3] New York Presbyterian Hosp, Columbia Presbyterian Med Ctr, Squier Urol Clin, New York, NY 10032 USA
关键词
D O I
10.1016/S0025-7125(03)00147-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lower urinary tract symptoms are common among men and a frequent reason for referral to an urologist. The most important information comes from the patient history because evaluation of symptoms is fundamental in the diagnosis and treatment planning for lower urinary tract symptoms. Other aspects of the initial evaluation, such as the physical examination and initial laboratory values, can provide valuable additional information about the severity of the disease and the need for treatment. If treatment is warranted based on this information, additional diagnostic tests may be appropriate to set a pretreatment baseline, rule out other conditions, and plan treatment approach. Fortunately, a variety of effective medical and surgical treatments are available to treat this common disease.
引用
收藏
页码:281 / +
页数:30
相关论文
共 50 条
  • [1] CHANGING APPROACHES IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    SCHRODER, FH
    [J]. EUROPEAN UROLOGY, 1991, 20 : 63 - 67
  • [2] NONSURGICAL TREATMENT EVALUATION IN BENIGN PROSTATIC HYPERPLASIA PATIENTS
    BUZELIN, JM
    GLEMAIN, P
    LENORMAND, L
    [J]. EUROPEAN UROLOGY, 1993, 24 : 18 - 23
  • [3] Medicoeconomic aspects of benign prostatic hyperplasia medical treatment
    Lebdai, S.
    Azzouzi, A. R.
    Delongchamps, N. -B.
    Benchikh, A.
    Campeggi, A.
    Cornu, J. -N.
    Dumonceau, O.
    Faix, A.
    Fourmarier, M.
    Haillot, O.
    Lukacs, B.
    Mathieu, R.
    Misrai, V.
    Robert, G.
    de La Taille, A.
    Descazeaud, A.
    [J]. PROGRES EN UROLOGIE, 2016, 26 (02): : 129 - 136
  • [4] Evaluation of symptoms in patients with benign prostatic hyperplasia
    Cornu, Jean-Nicolas
    Roupret, Morgan
    [J]. PROGRES EN UROLOGIE, 2007, 17 (05): : 1023 - 1025
  • [5] CHANGING PERSPECTIVES IN BENIGN PROSTATIC HYPERPLASIA
    NACEY, J
    DELAHUNT, B
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1995, 108 (1004) : 283 - 284
  • [6] EVALUATION OF HYDROXYPROGESTERONE CAPROATE IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    JACOBS, D
    HARPER, JM
    POLITANO, VA
    [J]. SOUTHERN MEDICAL JOURNAL, 1967, 60 (11) : 1174 - &
  • [7] FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - A URODYNAMIC EVALUATION
    KIRBY, RS
    BRYAN, J
    EARDLEY, I
    CHRISTMAS, TJ
    LIU, S
    HOLMES, SAV
    VALE, JA
    SHANMUGANATHAN, K
    WEBB, JA
    [J]. BRITISH JOURNAL OF UROLOGY, 1992, 70 (01): : 65 - 72
  • [8] EVALUATION OF TREATMENT RESPONSE TO DRUGS IN BENIGN PROSTATIC HYPERPLASIA
    WEIN, AJ
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1990, 17 (03) : 631 - 640
  • [9] Economic evaluation of finasteride in benign prostatic hyperplasia treatment
    Nickel, JC
    McDonald, H
    Hux, M
    Brisson, M
    Bernard, L
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 35 - 36
  • [10] An economic evaluation of finasteride for treatment of benign prostatic hyperplasia
    Baladi, JF
    Menon, D
    Otten, N
    [J]. PHARMACOECONOMICS, 1996, 9 (05) : 443 - 454